In 2020, Ried et al. tested 20 CTCs samples from PCa patients, obtained with ISET®-CTC methodology, using the Immuno-Cyto-Chemistry staining (ICC) with PSA and protein antibodies, showing a positive result in almost all of the patients (18/20). The gene discussed is KLK3; the disease is posterior cortical atrophy.